Evidence map›Paper›PMID 29550740›Full record

ArticleThe International journal on drug policy2018

Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: A 24-month retrospective analysis of a nationally representative sample.

Thai Hoang, Hong Nguyen, Ray W Shiraishi, Mai Nguyen, Trista Bingham, Diep Nguyen, Tam Nguyen, Hao Duong, Sheryl Lyss, Hien Tran

Open access · greenAbstract read
In one paragraph

Article in The International journal on drug policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 4 countries.

Thai HoangCenters for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA. Electronic address: vph6@cdc.gov.
Hong NguyenCenters for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA.
Ray W ShiraishiCenters for Diseases Control and Prevention, Division of Global HIV and TB, USA.
Mai NguyenVietnam Administration of HIV/AIDS Control, Viet Nam.
Trista BinghamCenters for Diseases Control and Prevention, Division of Global HIV and TB, USA.
Diep NguyenVietnam Administration of HIV/AIDS Control, Viet Nam.
Tam NguyenVietnam Administration of HIV/AIDS Control, Viet Nam.
Hao DuongCenters for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA; The Partnership for Health Advancement in Vietnam (HAIVN), Viet Nam.
Sheryl LyssCenters for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA.
Hien TranVietnam Administration of HIV/AIDS Control, Viet Nam.
Centers for Disease Control and Prevention · USMinistry of Health · VN

Funding

CGH CDC HHS U2G GH001016Intramural CDC HHS CC999999PEPFAR
6 · The paper itself

Abstract

backgroundMethadone maintenance treatment (MMT) is highly effective for reducing heroin use and HIV transmission among people who inject opioids. We sought to measure and understand factors associated with continued heroin use, a critical factor affecting treatment outcome among MMT patients in Vietnam.

methodWe collected data from medical charts of a nationally representative sample of patients who were on MMT from May 2008 to December 2013. We selected 10 MMT clinics using probability proportional to size and 50 patients/clinic by systematic random sampling. Concurrent heroin use was defined by self-report/positive urine test recorded in patient charts during month 3, 6, 12, and 24 after MMT initiation. We used multivariable logistic regression to identify factors associated with concurrent heroin use over the first 24 months in treatment.

findingsAll clients used heroin at baseline; concurrent heroin use was 55% at month 3; 19%, 14.6% and 15.2% at month 6, 12, and 24, respectively. Having no family emotional/financial support at baseline versus having this support (AOR = 2.03; 95% confidence interval [CI] = 1.17-3.53); using heroin for <15 years versus ≥15 years at baseline (AOR = 1.55; 95% CI = 1.01-2.38); being HIV-infected/not on antiretroviral treatment (ART; AOR = 1.79; 95% CI = 1.07-2.98) or being HIV infected/on ART (AOR = 2.39; 95% CI = 1.61-3.55), versus not being HIV infected; baseline methamphetamine use versus non-use (AOR = 2.68; 95% CI = 1.08-6.65), were associated with increased odds of concurrent heroin use among patients.

conclusionThe association between concurrent heroin use among MMT patients and lack of family emotional/financial support, highlights the critical importance of these types of support for successful treatment. Association with shorter heroin use history suggests motivational enhancement may reduce concurrent heroin use. Living with HIV, whether on ART or not, is associated with increased concurrent heroin use and suggests safe injection commodities and education, and drug-drug interaction management, are needed for this subgroup. Though few MMT clients reported baseline methamphetamine use, its association with later heroin use suggests the need for effective methamphetamine use interventions.

Indexed as

Opiate Substitution TreatmentAdultFemaleHeroinHeroin DependenceHumansMaleMethadoneMiddle AgedRetrospective StudiesRisk FactorsVietnamYoung AdultHeroinMethadoneARTConcurrent heroin useHeroin useHIVMethadone maintenance treatment

Identifiers

PMID29550740
PMCPMC5981011
OpenAlexW2790165261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.